SCHEMBL19081863

SCHEMBL19081863

c1ccc(-c2ccc(-c3c4ccccc4c(-c4c5sc6ccc7ccccc7c6c5cc5oc6ccccc6c45)c4ccccc34)c3ccccc23)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 3/20 0.34
CYP1A1 P04798 2/20 0.34
TDP1 Q9NUW8 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
CYP1A2 P05177 1/20 0.34
FYN P06241 1/20 0.34
MAPK3 P27361 1/20 0.34
AHR P35869 1/20 0.34
PAX8 Q06710 1/20 0.34
KDM4E B2RXH2 4/20 0.33
KMT2A Q03164 2/20 0.33
MEN1 O00255 1/20 0.33
WEE1 P30291 1/20 0.32
MAPK1 P28482 1/20 0.31
ALDH1A1 P00352 3/20 0.31
MAPT P10636 2/20 0.31
HPGD P15428 2/20 0.31
CDC14B O60729 1/20 0.31
CDC14A Q9UNH5 1/20 0.31
ALOX15 P16050 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19081791 0.90 TDP1 (0.36) TDP1L3MBTL1AHRKDM4EKMT2A
SCHEMBL19081899 0.87 TDP1 (0.37) ABCG2CYP1A1TDP1L3MBTL1CYP1A2
SCHEMBL19081865 0.86 ABCG2 (0.34) ABCG2CYP1A1TDP1L3MBTL1CYP1A2
SCHEMBL19081935 0.85 TDP1 (0.34) ABCG2CYP1A1TDP1L3MBTL1CYP1A2
SCHEMBL19082187 0.81 CHEK1 (0.35) CYP1A1TDP1KDM4EKMT2AMEN1
SCHEMBL19082193 0.81 TNKS (0.37) ABCG2CYP1A1L3MBTL1CYP1A2FYN
SCHEMBL19081988 0.81 TDP1 (0.34) ABCG2CYP1A1TDP1L3MBTL1CYP1A2
SCHEMBL19082078 0.79 TDP1 (0.30) TDP1L3MBTL1
SCHEMBL19076767 0.78 ALOX5 (0.35) ABCG2CYP1A1CYP1A2FYNMAPK3
SCHEMBL19082009 0.78 ESR1 (0.34) WEE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 ABCG2 4823/4885CYP1A1 184/4885TDP1 2322/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 ABCG2 4823/4885CYP1A1 184/4885TDP1 2322/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.